Canada markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1100+0.0050 (+4.76%)
At close: 10:52AM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 14.50M
Enterprise Value 22.07M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.07
Price/Book (mrq)107.98
Enterprise Value/Revenue 8.04
Enterprise Value/EBITDA -7.35

Trading Information

Stock Price History

Beta (5Y Monthly) 0.55
52-Week Change 30.00%
S&P500 52-Week Change 326.89%
52 Week High 30.1400
52 Week Low 30.0500
50-Day Moving Average 30.0884
200-Day Moving Average 30.0836

Share Statistics

Avg Vol (3 month) 359.99k
Avg Vol (10 day) 376.49k
Shares Outstanding 5131.84M
Implied Shares Outstanding 6131.84M
Float 882.8M
% Held by Insiders 136.45%
% Held by Institutions 10.00%
Shares Short (Jan 31, 2024) 4954
Short Ratio (Jan 31, 2024) 40
Short % of Float (Jan 31, 2024) 4N/A
Short % of Shares Outstanding (Jan 31, 2024) 40.00%
Shares Short (prior month Dec 29, 2023) 45.6k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 13, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 13, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023


Profit Margin -157.48%
Operating Margin (ttm)-166.40%

Management Effectiveness

Return on Assets (ttm)-32.70%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.74M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)25.60%
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-4.32M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.62M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)9.2M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.37
Book Value Per Share (mrq)-0.07

Cash Flow Statement

Operating Cash Flow (ttm)-1.79M
Levered Free Cash Flow (ttm)-1.75M